SaterenW.B., TrimbleE.L., AbramsJ.How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol.2002; 20: 2109–2117.
2.
EvelynB., ToigoT., BanksD.Participation of racial/ethic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1994-1999. J Natl Med Assoc.2001; 93(suppl 12): 18S–24S.
3.
TherrienM., RamirezR.R.The Hispanic Population in the United States: March 2000. Current Population Reports. US Census Bureau, Washington DC; 2001: 20–535.
4.
ShaversV.L., BrownM.L.Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst.2002; 94: 334–357.
5.
RiesL.A.G., EisnerM.P., KosaryC.L., eds. SEER Cancer Statistics Review, 1973-1997.Bethesda, Md: National Cancer Institute; 2000.
6.
SwansonG.M., BailarJCIII. Selection and description of cancer clinical trials participants: science or happenstance?Cancer.2002; 95: 950–959.
7.
UnderwoodS.M., AlexanderG.A.Participation of minorities and women in clinical cancer research. Ann Epidemiol.2000; 10: S1–S2.
8.
BrownD.R., FouadM.N., Basen-EngquistK.Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol.2000; 10: S13–S21.
9.
GiulianoA.R., MokuauN., HughesC.Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol.2000; 10: S22–S34.